Oblique Therapeutics and the KTH Royal Institute of Technology (KTH) have entered into a strategic collaboration to analyse protein structures using supercomputers

Contributed by: PR Newswire

Tags

OBLIQUE-THERAPEUTICS

More Like This

Oblique Therapeutics has entered a research collaboration agreement with Eli Lilly and Company to apply the AbiProt® technology to generate antibodies to a high-value target

Oblique Therapeutics today announced that Dr. Jan Lundberg has joined the company as Scientific Advisor

PR Newswire associated0

Kinomica, King's College London and King's College Hospital NHS Foundation Trust to Present Research Abstract at the 2024 ASCO Annual Meeting

PR Newswire associated0

Tetra Pharm Technologies and Kvantify Announce Partnership to Accelerate the Discovery of Novel Drug Candidates Targeting the Endocannabinoid System

Chiesi Group Forges Alliance with Karolinska Institutet to Tackle Urgent Health Challenges

PR Newswire associated0

J INTS BIO Launches AI-Supercomputing Alliance to Transform Cancer Therapy

Recursion Announces Data Collaboration Deal with Tempus, Top 50 Supercomputer Ambition Powered by NVIDIA, and Updated Focus of Collaboration with Bayer to Precision Oncology

SK pharmteco Collaborates with Axle Informatics and the National Institutes of Health to Advance Rare Disease Gene Therapy Programs